OnKure Therapeutics Inc.

OKUR | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.10

+$0.04 (+1.31%)

At close: Sep 22, 2026, 4:00 PM ET

$3.10

$0 (0.00%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.31%

(1D)

Rating

Updated: Aug 11, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $125.54M

1D Range

2.97 3.11

52W Range

2.23 5.38

Valuation (TTM)

PE -0.87

PB 0.72

EV/EBITDA 0.89

Valuation (NTM)

Forward PE N/A

Forward PEG 0.05

Price Target $14

Cash Flow

FCF Yield -38.6%

SBC Adj. FCF Yield -48.1%

SBC Impact -24.7%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -23.8% | 47.4%

FCF 3Y | 5Y -23.9% | -12.4%

Returns

ROA -32.7%

ROE -49.0%

ROIC -35.9%

Financial Health

Net Cash

$176.39M

Current Ratio 26.75

Interest Coverage -7,767.50

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A ...

Sector Healthcare

Industry Biotechnology

Employees 45

IPO Date Apr 7, 2021

Website onkuretherapeutics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$14

Upside

+351.61%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞